M.D. Sass LLC’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-391,824
| Closed | -$72.3M | – | 34 |
|
|
2024
Q4 | $72.3M | Buy |
391,824
+70,652
| +22% | +$13M | 5.44% | 2 |
|
|
2024
Q3 | $63.3M | Buy |
321,172
+12,227
| +4% | +$2.41M | 4.68% | 10 |
|
|
2024
Q2 | $63.8M | Buy |
308,945
+159,492
| +107% | +$32.9M | 4.58% | 8 |
|
|
2024
Q1 | $40.5M | Sell |
149,453
-31,733
| -18% | -$8.6M | 4.57% | 9 |
|
|
2023
Q4 | $42.8M | Sell |
181,186
-3,268
| -2% | -$773K | 5.15% | 6 |
|
|
2023
Q3 | $36.1M | Buy |
184,454
+8,995
| +5% | +$1.76M | 4.86% | 5 |
|
|
2023
Q2 | $36.9M | Buy |
175,459
+25,288
| +17% | +$5.32M | 4.89% | 7 |
|
|
2023
Q1 | $30.3M | Buy |
150,171
+20,118
| +15% | +$4.06M | 3.78% | 9 |
|
|
2022
Q4 | $28.3M | Sell |
130,053
-8,361
| -6% | -$1.82M | 4.16% | 13 |
|
|
2022
Q3 | $27.2M | Buy |
+138,414
| New | +$27.2M | 4.99% | 9 |
|
|
2021
Q1 | – | Sell |
-39,841
| Closed | -$9.96M | – | 36 |
|
|
2020
Q4 | $9.96M | Sell |
39,841
-17,576
| -31% | -$4.39M | 2.13% | 21 |
|
|
2020
Q3 | $13M | Sell |
57,417
-14,328
| -20% | -$3.24M | 3.22% | 20 |
|
|
2020
Q2 | $12.5M | Sell |
71,745
-14,379
| -17% | -$2.51M | 3.32% | 18 |
|
|
2020
Q1 | $10.9M | Buy |
86,124
+9,523
| +12% | +$1.2M | 3.95% | 10 |
|
|
2019
Q4 | $11.7M | Sell |
76,601
-23,793
| -24% | -$3.63M | 2.77% | 21 |
|
|
2019
Q3 | $13.3M | Buy |
100,394
+54,014
| +116% | +$7.15M | 3.14% | 13 |
|
|
2019
Q2 | $6.58M | Buy |
+46,380
| New | +$6.58M | 1.52% | 26 |
|